News
-
-
PRESS RELEASE
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects. EBIT margin at 11.4%. Company anticipates revenue acceleration in the second half of 2023/24 -
PRESS RELEASE
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Carl Zeiss Meditec AG achieved 1.0% revenue growth in the first quarter of fiscal year 2023/24, reaching €475.0m. Earnings before interest and taxes (EBIT) declined to around €43.5m, with the EBIT margin at 9.2%. Revenue growth was primarily boosted by the equipment business and SBU Microsurgery -
PRESS RELEASE
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Carl Zeiss Meditec AG has approved a share buyback program of up to €150m, representing 1.7% of share capital, starting on 9 February 2024. The company may discontinue the program at any time -
-
-
-
-
LaMar’s Donuts Celebrates National Donut Day 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust High Income Long/Short Fund
-
Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
-
Pfister Faucets' American Plumber Stories Docuseries Wins Three Telly Awards
-
EQS-Adhoc: Vectron Systems AG: Vectron enters into Business Combination Agreement, resolves 10% capital increase without subscription rights of the shareholders and supports voluntary public acqusition offer
-
CPI PROPERTY GROUP publishes financial results for the first quarter of 2024
-
Leclanché SA: Publishes its Annual Report 2023 and Non-financial ESG Report
-
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
ACCOR - Description of own share buyback programme
-
ACCOR - Press release following the 2024 general meeting
-
Capital increase through exercise of subscription rights
-
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
Thales has completed the sale of its Ground Transportation Systems business